Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
TD SYNNEX Corporation (SNX) - free report >>
LexinFintech Holdings Ltd. Sponsored ADR (LX) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
TD SYNNEX Corporation (SNX) - free report >>
LexinFintech Holdings Ltd. Sponsored ADR (LX) - free report >>
Image: Bigstock
Top Ranked Value Stocks to Buy for May 8th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, May 8th:
Health Insurance Innovations, Inc. : This cloud-based technology platform and distributor of health insurance plans has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 6.1% over the last 60 days.
Health Insurance Innovations, Inc. Price and Consensus
Health Insurance Innovations, Inc. price-consensus-chart | Health Insurance Innovations, Inc. Quote
Health Insurance has a price-to-earnings ratio (P/E) of 6.67, compared with 7.70 for the industry. The company possesses a Value Score of A.
Health Insurance Innovations, Inc. PE Ratio (TTM)
Health Insurance Innovations, Inc. pe-ratio-ttm | Health Insurance Innovations, Inc. Quote
LexinFintech Holdings Ltd. (LX - Free Report) : This online consumer finance platform has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 16.3% over the last 60 days.
LexinFintech Holdings Ltd. Sponsored ADR Price and Consensus
LexinFintech Holdings Ltd. Sponsored ADR price-consensus-chart | LexinFintech Holdings Ltd. Sponsored ADR Quote
LexinFintech has a price-to-earnings ratio (P/E) of 8.18, compared with 8.40 for the industry. The company possesses a Value Score of A.
LexinFintech Holdings Ltd. Sponsored ADR PE Ratio (TTM)
LexinFintech Holdings Ltd. Sponsored ADR pe-ratio-ttm | LexinFintech Holdings Ltd. Sponsored ADR Quote
SYNNEX Corporation (SNX - Free Report) : This business process services provider has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 0.9% over the last 60 days.
SYNNEX Corporation Price and Consensus
SYNNEX Corporation price-consensus-chart | SYNNEX Corporation Quote
SYNNEX has a price-to-earnings ratio (P/E) of 8.96 compared with 15.90 for the industry. The company possesses a Value Score of A.
SYNNEX Corporation PE Ratio (TTM)
SYNNEX Corporation pe-ratio-ttm | SYNNEX Corporation Quote
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>